| Autor: |
Jeffrey C. Weinreb, Roger A. Rodby, Jerry Yee, Carolyn L. Wang, Derek Fine, Robert J. McDonald, Mark A. Perazella, Jonathan R. Dillman, Matthew S. Davenport |
| Jazyk: |
angličtina |
| Rok vydání: |
2021 |
| Předmět: |
|
| Zdroj: |
Kidney Medicine, Vol 3, Iss 1, Pp 142-150 (2021) |
| Druh dokumentu: |
article |
| ISSN: |
2590-0595 |
| DOI: |
10.1016/j.xkme.2020.10.001 |
| Popis: |
Inaugural consensus statements were developed and endorsed by the American College of Radiology (ACR) and National Kidney Foundation to improve and standardize the care of patients with kidney disease who have indication(s) to receive ACR-designated group II or group III intravenous gadolinium-based contrast media (GBCM). The risk of nephrogenic systemic fibrosis (NSF) from group II GBCM in patients with advanced kidney disease is thought to be very low (zero events following 4931 administrations to patients with estimated glomerular filtration rate [eGFR] |
| Databáze: |
Directory of Open Access Journals |
| Externí odkaz: |
|
